W. Gassmann

Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice

N. Schmitz, P. Dreger, B. Glass, 1997, British journal of haematology.

The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization.

T. Haferlach, M. Poetsch, C. Schoch, 1996, Blood.

Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.

B. Glass, W. Mueller-Ruchholtz, J. Steinmann, 1992, Blood.

High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease

N. Schmitz, T. Haferlach, P. Dreger, 1993, Annals of Hematology.

High‐dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential

N. Schmitz, A. Erbersdobler, B. Glass, 1991, British journal of haematology.

Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG.

E. Thiel, T. Haferlach, C. Schoch, 1996, Leukemia & lymphoma.

Acute megakaryoblastic leukemia.

H. Löffler, W. Gassmann, H. Löffler, 1995, Leukemia & lymphoma.